February 28, 2019
Two Japanese investigator-initiated trials (IITs) on sodium pyruvate, which has been seen as the potentially first treatment for hyperlactacidemia associated with mitochondrial disease, will be discontinued at the end of March after failing to demonstrate any significant improvement in the...read more